+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

CAR T-cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Anti-CD3 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD3 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Actinic Keratosis - Pipeline Insight, 2025 - Product Thumbnail Image

Actinic Keratosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Insight, 2025 - Product Thumbnail Image

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2025 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PI3K Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PI3K Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
CD 3 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD 3 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glucocorticoid Induced Tumor Necrosis Factor - Pipeline Insight, 2025 - Product Thumbnail Image

Glucocorticoid Induced Tumor Necrosis Factor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Brain Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Anti-PD-1 / Anti-PD-L1 Refractory Solid Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-PD-1 / Anti-PD-L1 Refractory Solid Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more